Morepen Laboratories Limited (BOM: 500288)
India
· Delayed Price · Currency is INR | Market Cap | 41.44B |
| Revenue (ttm) | 17.75B |
| Net Income (ttm) | 1.31B |
| Shares Out | 547.95M |
| EPS (ttm) | 2.53 |
| PE Ratio | 29.94 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 516,005 |
| Open | 76.02 |
| Previous Close | 75.52 |
| Day's Range | 75.25 - 77.60 |
| 52-Week Range | 38.11 - 100.80 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 8, 2024 |
About Morepen Laboratories
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-gout, anti-depressant, and anti-malarial drugs; and home diagnostic products, such as air purifiers, sphygmomanometer, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital... [Read more]
Financial Performance
In 2023, Morepen Laboratories's revenue was 17.02 billion, an increase of 19.68% compared to the previous year's 14.22 billion. Earnings were 961.60 million, an increase of 148.63%.
Financial StatementsNews
Morepen Labs shares surge 21% in last one week
Morepen Laboratories Ltd., a pharmaceutical company, has seen its share price increase by 21% over the last week. As of 12:08 PM on August 26, 2024, the stock is trading at ₹84.14 on the NSE, up 5.03%...